ARCHIVES

ODAC Reviews Post-Marketing Studies for Eight Indications

This article is from The Cancer Letter archive.

Vol. 29 No. 08 | February 21, 2003

Download PDF Visit The Full Archive

Related Articles

SPORE Eligibility, Cost Issues Clarified In Addendum To RFA

October 25, 1991

“Harm-Reduction” Products No Proven, IOM Report Says.

March 2, 2001

Jane Henney Said Tentative Choice For FDA Commissioner

May 22, 1998

Also MSKCC picks David Kissane to succeed Jimmie Holland as chairman of psychiatry and behavioral sciences.

October 24, 2003

NCI, NIH Hoping 12 Percent Budget Cut Will Not Be Applied To Them

October 2, 1981

Also in this 8-page issue: Vitamin E doesn’t prevent heart events, cancer, Women’s Health Study finds.

July 8, 2005